Needle-free Injection System Market Expansion to be Persistent During 2026
Needle-free
injection system is an innovative way to introduce medication into a
patient’s body. Unlike the conventional needle injection system,
needle-free injection do not penetrate through the skin. Needle-free
injection system is steadily emerging as an efficient way to
administer the medication with better patient compliance. There are
various advantages offered by needle-free injection system. This
system offers efficiency in administration of medication with better
patient compliance especially for children (vaccination), geriatric
patients (palliative and other care), and patients with chronic
diseases such as diabetes, GI tract disease, and multiple sclerosis
who need daily injection administration. Self-medication becomes
convenient with needle-free injection due to increased confidence
amongst user for self-medication and therefore it offers better
treatment adherence and improved quality of life. Needle-free
injection eliminates needle phobia, as medication is administered
through system such as jet injection system to the skin. Moreover,
needle-free injection system allows drug delivery of even viscous
drug, which is difficult with conventional needle syringe system.
Needle-free injection system also allows efficient delivery of
biological drugs, which are unstable due to risk of protein
denaturation. This is possible as needle-free injection system
maintains biological integrity and it does not have silicon oil or
tungsten material in its primary container. It is reusable and
delivers drug faster, as compared to conventional needle syringe
system due to hair size jet stream through which drug is
administered.
Get Exclusive
Sample Report at: http://bit.ly/2MWoKLg
Market Dynamics
Needle-free
injection system is continuously expanding its market footprint on
account of various factors. Increasing incidence of needle associated
injuries and needle phobia amongst children and adults is expected to
drive growth of needle-free injection system market. According to a
study published in Behavioral Neurology, 2014, around 3-4 % of the
world population faces needle phobia. This impacts their hospital or
clinic visits, as they avoid visiting such facilities due to fear of
exposure to needles. Needle phobia also impacts the vaccination
amongst children, as most of them perceives injecting vaccine as a
painful procedure. According to a study published in the Clinical
Journal of Pain in 2015, there were 12 billion vaccination every year
worldwide, most of which required injecting drug with a needle
syringe system. Increasing demand for vaccines and other biologic
products is another factor boosting growth of the needle-free
injection system market. According to the World Health Organization
(WHO) 2018, globally around 86% of infants are vaccinated against 26
diseases, however, 19.5 million children are unvaccinated leading to
death of 2-3 million children every year. Chronic disease such as
diabetes often needs daily dose of insulin, which has to be
administered through pain needles. This may lead to lack of adherence
to treatment due to lack of confidence to self-inject insulin.
Increasing research on biologics and biosimilar is another factor
expected to fuel growth of the market. Biologicals are increasingly
launched and prescribed to treat disease such as GI tract disease
(ulcerative colitis and Crohn’s disease), central nervous system
associated disease (multiple sclerosis and Alzheimer’s disease),
and cancer. Other factors such as increasing incidence of
communicable diseases caused due to conventional needle, increasing
geriatric population worldwide who need palliative care, and growing
awareness about safe injection practices are also expected to drive
growth of needle-free injection system market.
However, per unit
cost of needle-free injection may restrain the market growth. As this
system is relatively new and do not have wider penetration yet, its
use is still very limited. Moreover, developing economies where
vaccine need is increasing with growing population would find it
difficult to access this product.
Regional Insights
On the basis of
geography, the global needle-free injection system market is
segmented into North America, Latin America, Europe, Asia Pacific,
Middle East, and Africa. North America is a dominant region in the
global needle-free injection system market. This is due to high
prevalence of chronic diseases such as diabetes and cancer. According
to the American Cancer Society, 2018, cancer is the second leading
cause of death after cardio vascular disease in the U.S. Furthermore,
around 1.7 million new cancer cases were reported by 2017 in this
region. Rising number of biologic drug approval in the U.S. is
another factor driving growth of needle-free injection system market.
For instance, according to the data published by the U.S. FDA (United
States Food and Drug Administration) in the year 2017, more than 20
biologic formulation received FDA approval. Asia Pacific is
witnessing high growth in the needle-free injection system market, as
vaccine need is highest in this region. Moreover, this region has
high prevalence of lifestyle disease such as diabetes. According to
the 2017 Diabetes Atlas report, there were over 240 million diabetes
patients in this region.
Inquire Here
Before Purchase of Research Report @ http://bit.ly/2Y1DKIR
Competitive
Landscape
Some of the key
players operating in the market include Antares Pharma, Inc., Endo
International plc, Portal Instruments, Inc., Zogenix, PharmaJet,
Bioject Medical Technologies Inc., Medical International Technology,
Inc., PenJet Corporation, INJEX Pharma AG, National Medical Products
Inc., Valeritas, Inc., European Pharma Group, and Crossject SA.
Collaborations
amongst companies to develop the needle-free injection system would
also boost growth of needle-free injection system market. For
instance, in November 2017, Takeda Pharmaceutical and Portal
Instruments entered into collaboration agreement to develop the
needle-free drug delivery device with the Takeda Pharmaceuticals
biologic medicines for hepatitis, Crohn's disease etc.
Market Taxonomy
On the basis of
product type:
Prefilled
Fillable
On the basis of
delivery site:
Subcutaneous
Injectors
Intramuscular
Injectors
Intradermal
Injectors
On the basis of
product lifecycle:
Disposable
Reusable
On the basis of
technology:
Jet-based needle
free injector
Spring-based
needle free injector
Laser-powered
needle free injector
On the basis of
application:
Vaccine and
other biologic product delivery
Insulin Delivery
Others
On the basis of end
user:
Hospitals &
Clinics
Home based care
On the basis of
geography:
North America
Latin America
Europe
Asia Pacific
Middle East
Africa
About Coherent
Market Insights
Coherent Market
Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis,
consulting services, and competitive analysis through various
recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market
Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Comments
Post a Comment